Pembrolizumab (MK-3475) plus platinum and gemcitabine as first-line treatment of recurrent/metastatic head and neck squamous cell carcinoma (PIPER): a phase 2, multicentre, single-arm protocol study in Malaysia

Authors

Gwo Fuang Ho (ORCID: https://orcid.org/0000-0002-2620-9174)
Sok Ching Cheong (ORCID: https://orcid.org/0000-0002-6765-9542)
Annie Wai Yeeng Chai (ORCID: https://orcid.org/0000-0002-8015-6050)
Soo‐Hwang Teo (ORCID: https://orcid.org/0000-0002-0444-590X)
Yoke Fui Wong
Ibtisam Muhamad Nor
W.I. Wan Zamaniah (ORCID: https://orcid.org/0000-0002-4007-7091)
Abqariyah Yahya (ORCID: https://orcid.org/0000-0001-9158-415X)
Bawani Selvam
Kue Peng Lim (ORCID: https://orcid.org/0000-0002-5670-8070)
Chih Kiang Tan

Institutions

Hospital Kuala Lumpur (MY)
University of Malaya (MY)
Cancer Research Malaysia (MY)
National Cancer Institute (MY)

Publication Details

Journal: BMJ Open
Published: 2024-12-01
DOI: https://doi.org/10.1136/bmjopen-2023-076898
Citations: 3
Primary Topic: Head and Neck Cancer Studies
Type: article
Field-Weighted Citation Impact: 1.74

Funders

Yayasan Sime Darby
Universiti Malaya
Merck Sharp and Dohme

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Pembrolizumab (MK-3475) plus platinum and gemcitabine as first-line treatment of recurrent/metastatic head and neck squamous cell carcinoma (PIPER): a phase 2, multicentre, single-arm protocol study in Malaysia

Gwo Fuang Ho, Sok Ching Cheong, Annie Wai Yeeng Chai, Soo‐Hwang Teo et al.

Dec 1, 2024

3 citations

BMJ Open

Head and Neck Cancer Studies

1.74

article

Pembrolizumab (MK-3475) plus platinum and gemcitabine as first-line treatment of recurrent/metastatic head and neck squamous cell carcinoma (PIPER): a phase 2, multicentre, single-arm protocol study in Malaysia

Gwo Fuang Ho, Sok Ching Cheong, Annie Wai Yeeng Chai, Soo‐Hwang Teo, Yoke Fui Wong, Ibtisam Muhamad Nor, W.I. Wan Zamaniah, Abqariyah Yahya, Bawani Selvam, Kue Peng Lim, Chih Kiang Tan

December 1, 2024article en

3 citations

Abstract

No abstract available for this paper.

BMJ OpenVol. 14(12)

Hospital Kuala Lumpur (MY), University of Malaya (MY), Cancer Research Malaysia (MY), National Cancer Institute (MY)

Yayasan Sime Darby, Universiti Malaya, Merck Sharp and Dohme

Good health and well-being

Openalex Percentile: Top 15%

Head and Neck Cancer Studies

1.74

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Pembrolizumab (MK-3475) plus platinum and gemcitabine as first-line treatment of recurrent/metastatic head and neck squamous cell carcinoma (PIPER): a phase 2, multicentre, single-arm protocol study in Malaysia — Gwo Fuang Ho, Sok Ching Cheong, et al. · BMJ Open (2024) | TGRS Research Map | TGRS